docetaxel anhydrous has been researched along with hemicholinium 3 in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (hemicholinium 3) | Trials (hemicholinium 3) | Recent Studies (post-2010) (hemicholinium 3) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 963 | 1 | 34 |
Protein | Taxonomy | docetaxel anhydrous (IC50) | hemicholinium 3 (IC50) |
---|---|---|---|
Vesicular acetylcholine transporter | Homo sapiens (human) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holzapfel, K; Krause, BJ; Müller, SA; Seidl, C; Senekowitsch-Schmidtke, R; Treiber, U | 1 |
1 other study(ies) available for docetaxel anhydrous and hemicholinium 3
Article | Year |
---|---|
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Choline; Diffusion; Docetaxel; Hemicholinium 3; Humans; Male; Nitriles; Organic Cation Transport Proteins; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Taxoids; Tosyl Compounds; Tritium | 2009 |